FDA NDC Directory · JSON-LD · Markdown

NEVIRAPINE

NDC 33342-238 · HUMAN PRESCRIPTION DRUG · TABLET, EXTENDED RELEASE

Labeler / ManufacturerMacleods Pharmaceuticals Limited
Marketing categoryAbbreviated NDA (generic) · App ANDA206879
Dosage form / routeTABLET, EXTENDED RELEASE · ORAL
Active ingredientsNEVIRAPINE (400 mg/1)
Marketing started20171007
Package count1

External sources

Source: openFDA. Public-domain (CC0).